Literature DB >> 1739332

Medium chain acyl-CoA dehydrogenase deficiency.

E H Touma1, C Charpentier.   

Abstract

From 65 reported cases of medium chain acyl-CoA dehydrogenase deficiency, we found an average presenting age of 13.5 months and a mean age at death of 18.5 months. One quarter of patients died of a Reye-like syndrome and/or sudden infant death. In half the cases there had been at least one sibling death. Asymptomatic cases were not uncommon (12% of cases). The crises were generally induced by a prolonged fast and after a viral prodromal phase in three quarters of cases. The crises consisted of somnolence progressing to lethargy which could lead to coma. Vomiting was frequent (60% of cases). Seizures, which were found in 29% of cases, represented a bad prognosis. The physical examinations revealed frequently a variable and regressive anicteric hepatomegaly. Blood and urine analysis revealed in most instances hypoglycaemia (96% of cases) with hypoketonuria and sometimes metabolic acidosis. Hepatic and muscular cytolytic enzymes were frequently raised, as were plasma ammonia, urea, and uric acid. Plasma total or free carnitine concentrations, especially non-fasting, were diminished in most cases. Plasma saturated medium chain fatty acids and particularly unsaturated cis-4-decenoate were on the other hand raised during the crises or during fasting. Urinary organic acid analysis revealed a characteristic profile of medium chain aciduria: C6-C10 dicarboxylic acids, hydroxy acids, glycine conjugates, and carnitine conjugates. Oral loading tests with carnitine or phenylpropionate allow a precise diagnosis. The diagnosis is confirmed by specific assays in various tissues. Avoidance of prolonged fasting seems to be the mainstay of treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739332      PMCID: PMC1793557          DOI: 10.1136/adc.67.1.142

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  39 in total

1.  Molecular lesion in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Y Matsubara; K Narisawa; S Miyabayashi; K Tada; P M Coates
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

Review 2.  Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview.

Authors:  W J Rhead
Journal:  Prog Clin Biol Res       Date:  1990

Review 3.  Secondary carnitine deficiency.

Authors:  M Duran; N E Loof; D Ketting; L Dorland
Journal:  J Clin Chem Clin Biochem       Date:  1990-05

4.  Defects of metabolism of fatty acids in the sudden infant death syndrome.

Authors:  A J Howat; M J Bennett; S Variend; L Shaw; P C Engel
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

5.  Cis-4-decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  M Duran; L Bruinvis; D Ketting; J B de Klerk; S K Wadman
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

6.  A new patient with dicarboxylic aciduria suggestive of medium-chain Acyl-CoA dehydrogenase deficiency presenting as Reye's syndrome.

Authors:  J A Del Valle; M J Garcia; B Merinero; C Pérez-Cerdá; F Roman; A Jimenez; M Ugarte; M Martínez-Pardo; C Ludeña; C Camarero
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  Sudden child death and 'healthy' affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency.

Authors:  M Duran; M Hofkamp; W J Rhead; J M Saudubray; S K Wadman
Journal:  Pediatrics       Date:  1986-12       Impact factor: 7.124

8.  Genetic deficiency of medium-chain acyl coenzyme A dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes.

Authors:  P M Coates; D E Hale; C A Stanley; B E Corkey; J A Cortner
Journal:  Pediatr Res       Date:  1985-07       Impact factor: 3.756

9.  Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids.

Authors:  M Duran; G Mitchell; J B de Klerk; J P de Jager; M Hofkamp; L Bruinvis; D Ketting; J M Saudubray; S K Wadman
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

10.  Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.

Authors:  E Schmidt-Sommerfeld; D Penn; J Kerner; L L Bieber; T M Rossi; E Lebenthal
Journal:  J Pediatr       Date:  1989-10       Impact factor: 4.406

View more
  23 in total

Review 1.  The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population.

Authors:  Ulrich A Schatz; Regina Ensenauer
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

2.  Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.

Authors:  H H Huidekoper; J Schneider; T Westphal; F M Vaz; M Duran; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2006-08-02       Impact factor: 4.982

Review 3.  Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD).

Authors:  T F Lang
Journal:  J Inherit Metab Dis       Date:  2009-10-11       Impact factor: 4.982

Review 4.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

5.  Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis.

Authors:  C J Wilson; M P Champion; J E Collins; P T Clayton; J V Leonard
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

6.  Introduction to the age-related diagnosis (ARD) index: an age at presentation related index for diagnostic use.

Authors:  R A Harkness; E J Harkness
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Rett syndrome in a patient with medium chain acyl-CoA dehydrogenase deficiency.

Authors:  R P Beekman; N Hofstee; J A Smeitink; B T Poll-The; M Duran
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

8.  Medium-chain acyl-CoA dehydrogenase deficiency does not correlate with apparent life-threatening events and the sudden infant death syndrome: results from phenylpropionate loading tests and DNA analysis.

Authors:  J M Penzien; G Molz; U N Wiesmann; J P Colombo; R Bühlmann; B Wermuth
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

9.  Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK.

Authors:  R J Pollitt; J V Leonard
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

10.  Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.

Authors:  P T Clayton; M Doig; S Ghafari; C Meaney; C Taylor; J V Leonard; M Morris; A W Johnson
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.